mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.8 |